胸腔间隔膜的巨型动脉瘤:一种多学科的方法
Laura Fuertes-Kenneally1,2, Basilio Angulo-Lara3, Alberto Forteza Gil4
1Department of Cardiology, Dr Balmis General University Hospital of Alicante, Alicante, Spain.
JACC. Case reports
|February 21, 2024
概括
一个巨大的心房隔膜动脉瘤 (ASA) 与心房隔膜缺陷 (ASD) 被手术治疗. 这种罕见的疾病带来了栓塞风险,突出显示了需要关闭的病人与分流.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 血管医学 血管医学
背景情况:
- 巨型心房隔膜动脉瘤 (ASA) 是一种罕见的心脏异常.
- 与心房隔膜缺陷 (ASD) 相关的ASAs存在显著的栓塞风险.
- 对于与ASD相关的ASA,最佳的中风预防策略尚不清楚.
研究的目的:
- 报告一个巨大的心房隔膜动脉瘤与心房隔膜缺陷的病例.
- 描述这种罕见疾病的手术治疗方法.
- 讨论对预防中风的影响.
主要方法:
- 常规心声回声检查发现了一个巨大的ASA和ASD.
- 进行了ASA的外科切除.
- 使用心周贴片实现了ASD的关闭.
主要成果:
- 成功的手术切除了巨大的ASA.
- 成功关闭相关的ASD与心周贴片.
- 患者的ASA和ASD得到了有效的管理.
结论:
- 手术干预是管理ASD巨型ASA的可行选择.
- 由于栓塞风险,关闭与分流相关的ASA至关重要.
- 需要进一步的研究来确定这些患者的最佳中风预防.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


